Mural Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Mural Oncology and buy or sell other stocks, ETFs, and their options commission-free!About MURA
Mural Oncology Plc is a clinical-stage oncology company, which focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2.
CEOOwen Patrick Hughes, Jr.
CEOOwen Patrick Hughes, Jr.
Employees—
Employees—
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2017
Founded2017
Employees—
Employees—
MURA Key Statistics
Market cap35.34M
Market cap35.34M
Price-Earnings ratio-0.29
Price-Earnings ratio-0.29
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.74
52 Week high$4.74
52 Week low$0.95
52 Week low$0.95
Stock Snapshot
As of today, Mural Oncology(MURA) shares are valued at $2.04. The company's market cap stands at 35.34M, with a P/E ratio of -0.29.
During the trading day, Mural Oncology(MURA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $0.95 to a high of $4.74.
The stock's 52-week range extends from a low of $0.95 to a high of $4.74.
People also own
Based on the portfolios of people who own MURA. This list is generated using Robinhood data, and it’s not a recommendation.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.